| Latest | F'cast | |
|---|---|---|
| Div Yield | 1.7% | |
| Div Cover | 2.3 | |
| Op Mrgn | 12.0% | |
| ROCE | 25.5% |
| Latest | F'cast | |
|---|---|---|
| P/E | 25.5 | |
| PEG | 0.3 | |
| Pr/Revenue | 0.5 | |
| Pr/Book | 0.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 19.9% | |
| PBT | 77.0% | |
| EPS | 73.2% | |
| DPS | 25.0% |
| Year Ending | Revenue (€ m) | Pre-tax (€ m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-06 | 4,440.10 | 982.20 | 507.00¢ | 15.5 | 0.3 | +49% | 90.00¢ | 1.1% |
| 31-Dec-07 | 7,057.10 | (110.90) | 1,621.00¢ | 5.4 | 0.0 | +220% | 120.00¢ | 1.4% |
| 31-Dec-08 | 7,589.60 | 574.90 | 169.00¢ | 38.2 | n/a | -90% | 150.00¢ | 2.3% |
| 31-Dec-09 | 7,747.00 | 486.40 | 168.00¢ | 38.8 | n/a | -1% | 100.00¢ | 1.5% |
| 31-Dec-10 | 9,290.60 | 861.10 | 291.00¢ | 20.6 | 0.3 | +73% | 125.00¢ | 2.1% |
| Year Ending | Revenue (€ m) | Pre-tax (€ m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-11 | 10,276.40 | 1,218.14 | 704.97¢ | 10.5 | 0.1 | +142% | 145.89¢ | 1.9% |
| 31-Dec-12 | 10,550.70 | 1,381.89 | 723.82¢ | 10.3 | 3.9 | +3% | 157.29¢ | 2.1% |
| 31-Dec-13 | 10,702.04 | 1,649.51 | 750.17¢ | 9.9 | 2.7 | +4% | 171.83¢ | 2.3% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| Schering-Plough, Merck profits climb | 24-Jul-2007 | LA Times |
| Merck's 2nd-quarter profit rises | 24-Jul-2007 | Wall Street Journal |
| Another Quarter of Strong Results by Merck | 24-Jul-2007 | New York Times |
| Currency | Euro |
| Share Price | € 74.28 |
| Change Today | € -1.20 |
| % Change | -1.59 % |
| 52 Week High | € 86.55 |
| 52 Week Low | € 56.82 |
| Volume | 267,085 |
| Shares Issued | 64.62m |
| Market Cap | € 4,800.06m |
| Strong Buy | 5 |
| Buy | 1 |
| Neutral | 15 |
| Sell | 2 |
| Strong Sell | 5 |
| Total | 28 |

You are here: research